GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)
- Supplementary File 1:
PDF-Document (PDF, 393 KiB)
Velpurisiva, P.; Piel, B.P.; Lepine, J.; Rai, P. GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM). Bioengineering 2018, 5, 83. https://doi.org/10.3390/bioengineering5040083
Velpurisiva P, Piel BP, Lepine J, Rai P. GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM). Bioengineering. 2018; 5(4):83. https://doi.org/10.3390/bioengineering5040083
Chicago/Turabian StyleVelpurisiva, Praveena, Brandon P. Piel, Jack Lepine, and Prakash Rai. 2018. "GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)" Bioengineering 5, no. 4: 83. https://doi.org/10.3390/bioengineering5040083